Back to Search
Start Over
Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study
- Source :
- Alzheimers research & therapy, 12(1):167. BioMed Central Ltd, Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020), Zaguán. Repositorio Digital de la Universidad de Zaragoza, instname, Alzheimer's research & therapy 12(1), 167 (2020). doi:10.1186/s13195-020-00734-y, Alzheimer's Research & Therapy, Alzheimer's Research & Therapy, 2020, 12 (167), ⟨10.1186/s13195-020-00734-y⟩, Zaguán: Repositorio Digital de la Universidad de Zaragoza, Universidad de Zaragoza
- Publication Year :
- 2020
-
Abstract
- International audience; Background: Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer's disease (AD) and other dementias, but its prevalence is not well known. We aimed to use uniform criteria to better estimate SCD prevalence across international cohorts. Methods: We combined individual participant data for 16 cohorts from 15 countries (members of the COSMIC consortium) and used qualitative and quantitative (Item Response Theory/IRT) harmonization techniques to estimate SCD prevalence. Results: The sample comprised 39,387 cognitively unimpaired individuals above age 60. The prevalence of SCD across studies was around one quarter with both qualitative harmonization/QH (23.8%, 95%CI = 23.3-24.4%) and IRT (25.6%, 95%CI = 25.1-26.1%); however, prevalence estimates varied largely between studies (QH 6.1%, 95%CI = 5.1-7.0%, to 52.7%, 95%CI = 47.4-58.0%; IRT: 7.8%, 95%CI = 6.8-8.9%, to 52.7%, 95%CI = 47.4-58.0%). Across studies, SCD prevalence was higher in men than women, in lower levels of education, in Asian and Black African people compared to White people, in lower- and middle-income countries compared to high-income countries, and in studies conducted in later decades. Conclusions: SCD is frequent in old age. Having a quarter of older individuals with SCD warrants further investigation of its significance, as a risk stage for AD and other dementias, and of ways to help individuals with SCD who seek medical advice. Moreover, a standardized instrument to measure SCD is needed to overcome the measurement variability currently dominant in the field.
- Subjects :
- Male
Aging
epidemiology [Cognitive Dysfunction]
Black african
Epidemiology
Disease
Neuropsychological Tests
MINI-MENTAL-STATE
lcsh:RC346-429
lcsh:RC321-571
Cohort Studies
Medical advice
PEOPLE
Prevalence
Medicine
Humans
CRITERIA
Cognitive Dysfunction
ddc:610
Cognitive decline
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
lcsh:Neurology. Diseases of the nervous system
business.industry
Research
Data harmonization
Individual participant data
DEMENTIA
subjective cognitive decline, prevalence, epidemiology, individual participant data, data harmonization, cohort study
Middle Aged
PERFORMANCE
FRAMEWORK
COMMUNITY
Subjective cognitive decline
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Female
DETERIORATION
HEALTH
business
Cohort study
MEMORY COMPLAINTS
Demography
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Alzheimers research & therapy, 12(1):167. BioMed Central Ltd, Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-14 (2020), Zaguán. Repositorio Digital de la Universidad de Zaragoza, instname, Alzheimer's research & therapy 12(1), 167 (2020). doi:10.1186/s13195-020-00734-y, Alzheimer's Research & Therapy, Alzheimer's Research & Therapy, 2020, 12 (167), ⟨10.1186/s13195-020-00734-y⟩, Zaguán: Repositorio Digital de la Universidad de Zaragoza, Universidad de Zaragoza
- Accession number :
- edsair.doi.dedup.....17044fd6fa103b22d9f8e1bf2c2d5245
- Full Text :
- https://doi.org/10.1186/s13195-020-00734-y